← Back
$NMRA All transactions

Neumora Therapeutics, Inc.

A

$ Value

Shares

46,455

Price

Filed

May 30

Insider

Name

Piacquad David

Title

CIK

0001602343

Roles

Director

Transaction Details

Transaction Date

2025-05-28

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

46,455

Footnotes

1/36th of the shares subject to the option vest on each monthly anniversary measured from September 8, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date. | On May 28, 2025, the Issuer's stockholders approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. | 100% of the shares subject to the option shall vest on the earlier of (i) one year anniversary of June 13, 2024 or (ii) immediately prior to the next Annual Meeting following June 13, 2024. | On May 28, 2025, the Issuer's stockholders approved an option repricing at an exercise price of $0.72 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. | 100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 28, 2025 or (ii) immediately prior to the next Annual Meeting following May 28, 2025.

Filing Info

Accession No.

0000950170-25-079921

Form Type

4

Issuer CIK

0001885522

Piacquad David's History

Date Ticker Type Value
2025-05-28 NMRA D
2025-05-28 NMRA D
2025-05-28 NMRA A
2025-05-28 NMRA A
2025-05-28 NMRA A $0

Other Insiders at NMRA (90d)

No other insider activity at this issuer in the last 90 days.